Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 10/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.47 |
| ▸ | CDC7 | O00311 | 1/20 | 0.47 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17694561 | 0.80 | NOTUM (0.78) | NOTUMLMNAALDH1A1MAPTHTT | |
| SCHEMBL2610163 | 0.78 | NOTUM (0.75) | NOTUMLMNAALDH1A1MAPTHTT | |
| SCHEMBL860256 | 0.71 | NOTUM (0.64) | NOTUMLMNAALDH1A1MAPTHTT | |
| SCHEMBL19356867 | 0.71 | NOTUM (0.64) | NOTUMLMNAALDH1A1MAPTHTT | |
| SCHEMBL5571187 | 0.71 | NOTUM (0.91) | NOTUMLMNAALDH1A1MAPTHTT | |
| SCHEMBL3685411 | 0.71 | NOTUM (0.64) | NOTUMLMNAALDH1A1MAPTHTT | |
| SCHEMBL14814390 | 0.71 | NOTUM (1.00) | NOTUMLMNAALDH1A1MAPTHTT | |
| SCHEMBL9096052 | 0.71 | NOTUM (0.64) | NOTUMLMNAALDH1A1MAPTHTT | |
| SCHEMBL3537328 | 0.71 | NOTUM (1.00) | NOTUMLMNAALDH1A1MAPTHTT | |
| SCHEMBL368913 | 0.71 | NOTUM (0.64) | NOTUMLMNAALDH1A1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090156827-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT | TOYO INK MFG. CO., LTD. (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20090156827-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT | TOYO INK MFG. CO., LTD. (JP) | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156827-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT | ELP1, ELAVL1, ELF3 | NOTUM 3406/4885LMNA 1330/4885ALDH1A1 1089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.